IRIS Accounts Production v23.1.5.20 SC461777 director 1.4.22 31.3.23 31.3.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureSC4617772022-03-31SC4617772023-03-31SC4617772022-04-012023-03-31SC4617772021-03-31SC4617772021-04-012022-03-31SC4617772022-03-31SC461777ns16:Scotland2022-04-012023-03-31SC461777ns15:PoundSterling2022-04-012023-03-31SC461777ns11:Director12022-04-012023-03-31SC461777ns11:PrivateLimitedCompanyLtd2022-04-012023-03-31SC461777ns11:SmallEntities2022-04-012023-03-31SC461777ns11:AuditExemptWithAccountantsReport2022-04-012023-03-31SC461777ns11:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-31SC461777ns11:SmallCompaniesRegimeForAccounts2022-04-012023-03-31SC461777ns11:FullAccounts2022-04-012023-03-31SC46177712022-04-012023-03-31SC461777ns11:RegisteredOffice2022-04-012023-03-31SC461777ns6:CurrentFinancialInstruments2023-03-31SC461777ns6:CurrentFinancialInstruments2022-03-31SC461777ns6:Non-currentFinancialInstruments2023-03-31SC461777ns6:Non-currentFinancialInstruments2022-03-31SC461777ns6:ShareCapital2023-03-31SC461777ns6:ShareCapital2022-03-31SC461777ns6:RetainedEarningsAccumulatedLosses2023-03-31SC461777ns6:RetainedEarningsAccumulatedLosses2022-03-31SC461777ns6:NetGoodwill2022-04-012023-03-31SC461777ns6:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-31SC461777ns6:LeaseholdImprovements2022-04-012023-03-31SC461777ns6:PlantMachinery2022-04-012023-03-31SC461777ns6:FurnitureFittings2022-04-012023-03-31SC461777ns6:ComputerEquipment2022-04-012023-03-31SC461777ns6:NetGoodwill2022-03-31SC461777ns6:NetGoodwill2023-03-31SC461777ns6:NetGoodwill2022-03-31SC461777ns6:LeaseholdImprovements2022-03-31SC461777ns6:PlantMachinery2022-03-31SC461777ns6:FurnitureFittings2022-03-31SC461777ns6:ComputerEquipment2022-03-31SC461777ns6:LeaseholdImprovements2023-03-31SC461777ns6:PlantMachinery2023-03-31SC461777ns6:FurnitureFittings2023-03-31SC461777ns6:ComputerEquipment2023-03-31SC461777ns6:LeaseholdImprovements2022-03-31SC461777ns6:PlantMachinery2022-03-31SC461777ns6:FurnitureFittings2022-03-31SC461777ns6:ComputerEquipment2022-03-31SC461777ns6:WithinOneYearns6:CurrentFinancialInstruments2023-03-31SC461777ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-31SC461777ns6:Secured2023-03-31SC461777ns6:Secured2022-03-31SC461777ns6:DeferredTaxation2022-03-31SC461777ns6:DeferredTaxation2022-04-012023-03-31SC461777ns6:DeferredTaxation2023-03-31
REGISTERED NUMBER: SC461777 (Scotland)





















Unaudited Financial Statements

For The Year Ended 31 March 2023

for

Enhance Medicare Ltd

Enhance Medicare Ltd (Registered number: SC461777)






Contents of the Financial Statements
For The Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Accountants' Report 8

Enhance Medicare Ltd

Company Information
For The Year Ended 31 March 2023







DIRECTOR: Miss A Sheikh





REGISTERED OFFICE: 41 St. James Avenue
East Kilbride
Glasgow
G74 5QD





REGISTERED NUMBER: SC461777 (Scotland)





ACCOUNTANTS: Atkinson Donnelly LLP
1 Cambuslang Court
Cambuslang
Glasgow
Strathclyde
G32 8FH

Enhance Medicare Ltd (Registered number: SC461777)

Balance Sheet
31 March 2023

31.3.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 35,380 50,277
Tangible assets 5 102,639 117,354
138,019 167,631

CURRENT ASSETS
Stocks 8,600 8,000
Debtors 6 47,657 29,157
Cash at bank 132,614 101,410
188,871 138,567
CREDITORS
Amounts falling due within one year 7 45,523 34,684
NET CURRENT ASSETS 143,348 103,883
TOTAL ASSETS LESS CURRENT
LIABILITIES

281,367

271,514

CREDITORS
Amounts falling due after more than one
year

8

(19,494

)

(68,072

)

PROVISIONS FOR LIABILITIES 10 (19,502 ) (22,297 )
NET ASSETS 242,371 181,145

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 242,271 181,045
242,371 181,145

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Enhance Medicare Ltd (Registered number: SC461777)

Balance Sheet - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 21 November 2023 and were signed by:





Miss A Sheikh - Director


Enhance Medicare Ltd (Registered number: SC461777)

Notes to the Financial Statements
For The Year Ended 31 March 2023

1. STATUTORY INFORMATION

Enhance Medicare Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2014, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Improvements to property - 4% on cost
Plant and machinery - 33% on cost
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
Debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Cash and Bank Balances
Cash and bank balances are measured at the transaction price.


Enhance Medicare Ltd (Registered number: SC461777)

Notes to the Financial Statements - continued
For The Year Ended 31 March 2023

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2022 - 3 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2022
and 31 March 2023 148,970
AMORTISATION
At 1 April 2022 98,693
Charge for year 14,897
At 31 March 2023 113,590
NET BOOK VALUE
At 31 March 2023 35,380
At 31 March 2022 50,277

Enhance Medicare Ltd (Registered number: SC461777)

Notes to the Financial Statements - continued
For The Year Ended 31 March 2023

5. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and Computer
property machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 April 2022 92,287 229,634 79,159 17,852 418,932
Additions - 4,319 995 3,635 8,949
At 31 March 2023 92,287 233,953 80,154 21,487 427,881
DEPRECIATION
At 1 April 2022 19,523 208,748 60,352 12,955 301,578
Charge for year 3,692 12,888 4,951 2,133 23,664
At 31 March 2023 23,215 221,636 65,303 15,088 325,242
NET BOOK VALUE
At 31 March 2023 69,072 12,317 14,851 6,399 102,639
At 31 March 2022 72,764 20,886 18,807 4,897 117,354

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Trade debtors 573 3,808
Other debtors 47,084 25,349
47,657 29,157

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Bank loans and overdrafts 6,139 13,645
Taxation and social security 34,709 17,550
Other creditors 4,675 3,489
45,523 34,684

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.3.23 31.3.22
£    £   
Bank loans 19,494 68,072

Enhance Medicare Ltd (Registered number: SC461777)

Notes to the Financial Statements - continued
For The Year Ended 31 March 2023

9. SECURED DEBTS

The following secured debts are included within creditors:

31.3.23 31.3.22
£    £   
Bank loans 25,633 81,717

The Royal Bank of Scotland holds a floating charge over the company and its assets in respect of bank borrowings.

10. PROVISIONS FOR LIABILITIES
31.3.23 31.3.22
£    £   
Deferred tax 19,502 22,297

Deferred
tax
£   
Balance at 1 April 2022 22,297
Provided during year (2,795 )
Balance at 31 March 2023 19,502

Chartered Accountants' Report to the Director
on the Unaudited Financial Statements of
Enhance Medicare Ltd

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Enhance Medicare Ltd for the year ended 31 March 2023 which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of ICAS, we are subject to its ethical and other professional requirements which are detailed at http://www.icas.com/accountspreparationguidance.

This report is made solely to the director of Enhance Medicare Ltd in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Enhance Medicare Ltd and state those matters that we have agreed to state to the director of Enhance Medicare Ltd in this report in accordance with the requirements of ICAS as detailed at http://www.icas.com/accountspreparationguidance. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its director for our work or for this report.

It is your duty to ensure that Enhance Medicare Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Enhance Medicare Ltd. You consider that Enhance Medicare Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Enhance Medicare Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Atkinson Donnelly LLP
1 Cambuslang Court
Cambuslang
Glasgow
Strathclyde
G32 8FH


21 November 2023